© 2020 MJH Life Sciences™ and Modern Retina. All rights reserved.
AMD Nurturing Program
Brolucizumab: Next-generation of anti-VEGF therapy?
July 21, 2018
Intravitreal implant could bring significant cost savings to NHS England
February 26, 2018
A study has revealed that a budgetary saving per treated patient with the fluocinolone acetonide implant (Iluvien) versus ranibizumab (Lucentis) could lead to a significant cost-saving to NHS England.